COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Yusuke Asai
Institution
AMR Clinical Reference Center
Address
Tokyo
Japan
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2012
1
2015
1
2016
2
2017
4
2018
1
2019
2
2020
7
2021
8
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Matsunaga N
,
Hayakawa K
,
Terada M
,
Ohtsu H
,
Asai Y
,
Tsuzuki S
,
Suzuki S
,
Toyoda A
,
Suzuki K
,
Endo M
,
Fujii N
,
Suzuki M
,
Saito S
,
Uemura Y
,
Shibata T
,
Kondo M
,
Izumi K
,
Terada-Hirashima J
,
Mikami A
,
Sugiura W
,
Ohmagari N
. Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan. Clin Infect Dis. 2021 12 06; 73(11):e3677-e3689.
PMID:
32986793
.
Citations:
27
Fields:
Com
Communicable Diseases
Translation:
Humans
Togano T
,
Uemura Y
,
Asai Y
,
Hayakawa K
,
Matsunaga N
,
Terada M
,
Ohtsu H
,
Suzuki S
,
Toyoda A
,
Hara H
,
Sato R
,
Ishikane M
,
Kinoshita-Iwamoto N
,
Hangaishi A
,
Ohmagari N
. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Oct; 27(10):1498-1503.
PMID:
34340930
.
Citations:
1
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
Iwanami S
,
Ejima K
,
Kim KS
,
Noshita K
,
Fujita Y
,
Miyazaki T
,
Kohno S
,
Miyazaki Y
,
Morimoto S
,
Nakaoka S
,
Koizumi Y
,
Asai Y
,
Aihara K
,
Watashi K
,
Thompson RN
,
Shibuya K
,
Fujiu K
,
Perelson AS
,
Iwami S
,
Wakita T
. Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study. PLoS Med. 2021 07; 18(7):e1003660.
PMID:
34228712
.
Citations:
4
Fields:
Med
Medicine (General)
Translation:
Humans
Terada M
,
Ohtsu H
,
Saito S
,
Hayakawa K
,
Tsuzuki S
,
Asai Y
,
Matsunaga N
,
Kutsuna S
,
Sugiura W
,
Ohmagari N
. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021 06 15; 11(6):e047007.
PMID:
34130961
.
Citations:
3
Fields:
Med
Medicine (General)
Translation:
Humans
Ide S
,
Hayama H
,
Asai Y
,
Terada M
,
Nomoto H
,
Kutsuna S
,
Ohmagari N
,
Hiroi Y
. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019. Circ J. 2021 05 25; 85(6):944-947.
PMID:
33994409
.
Citations:
Fields:
Car
Cardiology
Vas
Vascular Diseases
Translation:
Humans
Cells
Yamada G
,
Hayakawa K
,
Asai Y
,
Matsunaga N
,
Ohtsu H
,
Hojo M
,
Hashimoto M
,
Kobayashi K
,
Sasaki R
,
Okamoto T
,
Yanagawa Y
,
Katagiri D
,
Terada M
,
Suzuki M
,
Sato L
,
Miyazato Y
,
Ishikane M
,
Morioka S
,
Saito S
,
Ohmagari N
. External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050.
PMID:
33865699
.
Citations:
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
Kim KS
,
Ejima K
,
Iwanami S
,
Fujita Y
,
Ohashi H
,
Koizumi Y
,
Asai Y
,
Nakaoka S
,
Watashi K
,
Aihara K
,
Thompson RN
,
Ke R
,
Perelson AS
,
Iwami S
. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2. PLoS Biol. 2021 03; 19(3):e3001128.
PMID:
33750978
.
Citations:
8
Fields:
Bio
Biology
Translation:
Humans
Cells
Kutsuna S
,
Asai Y
,
Matsunaga A
,
Kinoshita N
,
Terada M
,
Miyazato Y
,
Nakamoto T
,
Suzuki T
,
Saito S
,
Endo M
,
Kanda K
,
Kenji M
,
Takasaki J
,
Hojo M
,
Ishizaka Y
,
Ohmagari N
. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813.
PMID:
33531292
.
Citations:
3
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
Asai Y
,
Tsuzuki S
,
Kutsuna S
,
Hayakawa K
,
Ohmagari N
. Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study. J Infect Chemother. 2021 Mar; 27(3):515-520.
PMID:
33380364
.
Citations:
Fields:
Ant
Anti-Infective Agents
Com
Communicable Diseases
Dru
Drug Therapy
Mic
Microbiology
Translation:
Humans
PH
Public Health
Katagiri D
,
Ishikane M
,
Asai Y
,
Izumi S
,
Takasaki J
,
Katsuoka H
,
Kondo I
,
Ide S
,
Nakamura K
,
Nakamoto T
,
Nomoto H
,
Akiyama Y
,
Miyazato Y
,
Suzuki T
,
Kinoshita N
,
Ogawa T
,
Togano T
,
Suzuki M
,
Hashimoto M
,
Sakamoto K
,
Kusaba Y
,
Katsuno T
,
Fukaya T
,
Hojo M
,
Sugiyama M
,
Mizokami M
,
Okamoto T
,
Kimura A
,
Noiri E
,
Ohmagari N
,
Hinoshita F
,
Sugiyama H
. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
PMID:
33325084
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Saito S
,
Asai Y
,
Matsunaga N
,
Hayakawa K
,
Terada M
,
Ohtsu H
,
Tsuzuki S
,
Ohmagari N
. First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2021 04; 82(4):84-123.
PMID:
33152376
.
Citations:
41
Fields:
Com
Communicable Diseases
Translation:
Humans
Kutsuna S
,
Asai Y
,
Matsunaga A
. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. N Engl J Med. 2020 10 22; 383(17):1695-1696.
PMID:
32966712
.
Citations:
9
Fields:
Med
Medicine (General)
Translation:
Humans
Cells
PH
Public Health
Katagiri D
,
Ishikane M
,
Asai Y
,
Kinoshita N
,
Ota M
,
Moriyama Y
,
Ide S
,
Nakamura K
,
Nakamoto T
,
Nomoto H
,
Akiyama Y
,
Miyazato Y
,
Suzuki T
,
Okuhama A
,
Kanda K
,
Wakimoto Y
,
Morioka S
,
Saito S
,
Yamamoto K
,
Ujiie M
,
Hayakawa K
,
Kustuna S
,
Yanagawa Y
,
Terada J
,
Takasaki J
,
Izumi S
,
Hojo M
,
Hinoshita F
,
Sugiyama M
,
Noiri E
,
Mizokami M
,
Ohmagari N
,
Sugiyama H
. Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
PMID:
32766565
.
Citations:
4
Nakamura K
,
Ide S
,
Saito S
,
Kinoshita N
,
Kutsuna S
,
Moriyama Y
,
Suzuki T
,
Ota M
,
Nomoto H
,
Mizoue T
,
Hojo M
,
Takasaki J
,
Asai Y
,
Terada M
,
Akiyama Y
,
Miyazato Y
,
Nakamoto T
,
Wakimoto Y
,
Ujiie M
,
Yamamoto K
,
Ishikane M
,
Morioka S
,
Hayakawa K
,
Sugiyama H
,
Ohmagari N
. COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
PMID:
33330803
.
Citations:
1
Kutsuna S
,
Suzuki T
,
Hayakawa K
,
Tsuzuki S
,
Asai Y
,
Suzuki T
,
Ide S
,
Nakamura K
,
Moriyama Y
,
Kinoshita N
,
Hosokawa N
,
Osawa R
,
Yamamuro R
,
Akiyama Y
,
Miyazato Y
,
Nomoto H
,
Nakamoto T
,
Ota M
,
Saito S
,
Ishikane M
,
Morioka S
,
Yamamoto K
,
Ujiie M
,
Terada M
,
Nakamura-Uchiyama F
,
Sahara T
,
Sano M
,
Imamura A
,
Sekiya N
,
Fukushima K
,
Kawana A
,
Fujikura Y
,
Sano T
,
Suematsu R
,
Sakamoto N
,
Nagata K
,
Kato T
,
Katano H
,
Wakita T
,
Sugiyama H
,
Kokudo N
,
Ohmagari N
. SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
PMID:
32754627
.
Citations:
4
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs
Asai's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (98)
Derived automatically from this person's publications.
Cholera
Microcephaly
Forecasting
Measles
Yemen
Explore
_
Co-Authors (124)
People in Profiles who have published with this person.
Nishiura, Hiroshi
Ohmagari, Norio
Kutsuna, Satoshi
Tsuzuki, Shinya
Terada, Mari
Explore
_
Similar People (60)
People who share similar concepts with this person.
Azman, Andrew
Wiwanitkit, Viroj
Ryan, Edward
Nishiura, Hiroshi
Joob, Beuy
Explore
_